STOCKS SURGE AFTER SOFT U.S. JOBS PRINT, SOLID APPLE RESULTS

Jobs report pushes up bets on a sooner-than-expected interest rate cut from the Fed

GILD Jun 2024 85.000 call

OPR - OPR Delayed Price. Currency in USD

Add to watchlist

0.0500

0.0000

(0.00%)

As of 11:11AM EDT. Market open.

Loading interactive chart...

Zacks
The Zacks Analyst Blog Highlights Gilead Sciences, GSK, Deciphera, Bristol Myers and Editas Medicine
Gilead Sciences, GSK, Deciphera, Bristol Myers and Editas Medicine are included in this Analyst Blog.
Zacks
Biotech Stock Roundup: GILD's GSK' Q1 Earnings, DCPH Soars on Acquisition News & More
Deciphera Pharmaceuticals, Inc. (DCPH) and GSK are in focus on acquisition news and Q1 earnings, respectively.
Business Wire
Gilead Sciences to Present at Upcoming Investor Conferences
FOSTER CITY, Calif., April 30, 2024--Gilead Sciences, Inc. (Nasdaq: GILD) announced today that its executives will be speaking at the following investor conferences: